Technical Data
S8400
Surfactant Protein A (SP-A)
Description:
There are four main surfactant proteins, known as SP-A, B, C, and D. SP-A was the first surfactant protein to be identified, and is also the most abundant. Its molecular mass varies from 26-38kD. It can be found in an open or closed form depending on the other substances present in the system. Calcium ions produce the closed-bouquet form. SP-A is necessary for the production of tubular myelin, a lipid transport structure unique to the lungs.

Applications:
Suitable for use in Immunohistochemistry, Western Blot and ELISA. Other applications have not been tested.

Recommended Dilutions:
Immunohistochemistry: 1:4000-1:8000 with and without antigen retrieval. See Protocol.
Western Blot: 1:500. Detected glycosylated and unglycosylated isoforms of SP-A on 10ug of rat lung lysates; Band at ~26kD.
ELISA: 1:500-1:1000
Optimal dilutions to be determined by the researcher.

Recommended Secondary Antibodies:
I1904-39: IgG, X-Adsorbed (HRP) Pab Gt x Rb
I1904-40A: IgG, H&L, X-Adsorbed (HRP) Pab Gt x Rb
I1904-46Q: IgG, H&L (HRP) Pab Gt x Rb
I1904-43: IgG, X-Adsorbed (Biotin) Pab Gt x Rb
I1904-40E: IgG, H&L (Biotin) Pab Gt x Rb
I1904-46P: IgG, H&L (Biotin) Pab Gt x Rb
I1904-42T: IgG, H&L (Biotin) Pab Gt x Rb
I1904-42V: IgG, H&L (Biotin) Pab Gt x Rb

Recommended Control:
Lung tissue, lung lavage

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
PabIgGSerum
SizeStorageShippingSourceHost
100ul-20°CBlue IceHumanRabbit
Concentration:
Not Determined
Immunogen:
Human SP-A (deglycosylated, beta-eliminated) purified from human alveolar proteinosis material.
Purity:
Serum
Form
Supplied as a liquid in PBS. No preservative added.
Specificity:
Reacts strongly with both glycosylated and unglycosylated isoforms of human SP-A at 26kD. Immunostains alveolar Type II cells, macrophages, and alveolar proteinosis material in both human proteinosis and in animal models of alveolar proteinosis. Species Crossreactivity: primate, rat and mouse.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Stahlman, M.T., et al., Pediatr. Res. 31: 364-371 (1992). 2. Khoor, A., et al., J. Histochem. Cytochem. 42: 1187-1199 (1994). 3. Coalson, J.J., et al., Am. J. Respir. Crit. Care Med. 151: 854-866 (1995). 4. Jennings, V.M., et al., Am. J. Respir. Cell Mol. Biol. 13: 297-306 (1995). 5. Vorbroker, D.K., et al., Am. J. Physiol. 268: (Lung. Cell Mol. Physiol. 13) L647-L656 (1995). 6. Wert, S.E., et al., Am. J. Respir. Crit. Care Med. 149: A244 (1994). 7. Wert, S.E., et al., Pediatr. Res. 39: 355A (1996). 8. Wert, S.E., et al., Pediatr. Res. 37: 356A (1995). 9. Morotti, R.A., et al., Human Pathology 30: 618-625 (1999). 10. Nogee, L.M., et al., Am. J. Respir. Crit. Care Med. 161: 973-981 (2000). 11. Shi, S-R., et al., J. Histochem. Cytochem. 39: 741-748 (1991). 12. Gown, A.M. & Leong, A., Appl. Immunohistochem. 14: 267-274 (1993). 13. Zhou, L., et al., Dev. Biol. 175: 227-238 (1996). 14. Zhou, L., et al., J. Histochem. Cytochem. 44: 1183-1193 (1996). 15. Jain-Vora, S., et al., Am. J. Respir. Cell Mol. Biol. 17: 1-11 (1997). 16. Zsengeller, Z.K., et al., Hum. Gene Ther. 8: 1331-1344 (1997). 17. Tokieda, K., et al., Am. J. Respir. Cell and Mol. Biol. 21: 463-472 (1999).9).